Most read article(s)

Research Article
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
Barbara A. Hanson, Lavanya Visvabharathy, Sareen T. Ali, et al.

March 07, 2022
Article
Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody
Keisuke Yoshikawa, Motoi Kuwahara, Miyuki Morikawa, et al.

September 15, 2020
Views & Reviews
Autoimmune NeurologyThe Need for Comprehensive Care
Justin R. Abbatemarco, Stefanie J. Rodenbeck, Gregory S. Day, et al.

June 15, 2021
Clinical/Scientific Note
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies
Chiara Briani, Andrea Visentin, Francesca Castellani, et al.

May 16, 2022
Article
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Moli Fan, Wei Qiu, Bitao Bu, et al.

June 04, 2020
Research Article
Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple SclerosisClinical, Radiographic, and Laboratory Data
William M. Rowles, Wan-Yu Hsu, Kira McPolin, et al.

May 17, 2022
Article
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.

November 16, 2021
Article
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts
Giulia Berzero, Giulia Campanini, Elisa Vegezzi, et al.

January 12, 2021
Article
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19Systematic Review and Meta-synthesis
Giovanna S. Manzano, Caleb R. S. McEntire, Maria Martinez-Lage, et al.

August 27, 2021
Article
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
Farren Basil Shaw Briggs, Farrah J. Mateen, Hollie Schmidt, et al.

November 09, 2021

Pages